Xencor (XNCR) Non Operating Investment Income (2015 - 2023)
Xencor (XNCR) reported Non Operating Investment Income of $1.2 million for Q3 2023, up 228.89% year-over-year from $364859.6 in Q3 2022, and down 32.01% quarter-over-quarter from $1.8 million in Q2 2023.
Xencor (XNCR) Non Operating Investment Income (2015 - 2023) Analysis & Trends
Xencor (XNCR) has 9 years of Non Operating Investment Income data on file, last reported at $1.2 million in Q3 2023.
- Non Operating Investment Income for Q3 2023 came in at $1.2 million, up 228.89% year-over-year; the trailing twelve-month figure through Sep 2023 was $9.2 million (up 194.44% YoY), and the FY2022 annual result was -$5.4 million, down 243.56% from the prior year.
- Non Operating Investment Income fell to $1.2 million in Q3 2023 per XNCR's latest filing, from $1.8 million in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $3.3 million in Q1 2023 and troughed at -$5.6 million in Q1 2022.
- A 5-year average of $18631.6 and a median of -$105000.0 in 2020 frame the typical range for Non Operating Investment Income.
- The sharpest annual moves came in 2019 and 2022: Non Operating Investment Income jumped 565.28% in 2019, then sank 24447.83% in 2022.
- A 5-year view of Non Operating Investment Income shows it stood at -$275000.0 in 2019, then sank by 79.27% to -$493000.0 in 2020, then slumped by 191.08% to -$1.4 million in 2021, then jumped by 306.13% to $3.0 million in 2022, then sank by 59.43% to $1.2 million in 2023.
- Business Quant data shows XNCR's Non Operating Investment Income at $1.2 million in Q3 2023, $1.8 million in Q2 2023, and $3.3 million in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 230,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.77 Mn |
| Jun 30, 2023 | 1.77 Mn |
| Mar 31, 2023 | 3.30 Mn |
| Mar 31, 2023 | 3.30 Mn |
| Dec 31, 2022 | 2.96 Mn |
| Dec 31, 2022 | 2.96 Mn |
| Sep 30, 2022 | -931,000.00 |
| Sep 30, 2022 | -931,000.00 |
| Jun 30, 2022 | -1.80 Mn |
| Jun 30, 2022 | -1.80 Mn |
| Mar 31, 2022 | -5.60 Mn |
| Mar 31, 2022 | -5.60 Mn |
| Dec 31, 2021 | -1.44 Mn |
| Dec 31, 2021 | -1.44 Mn |
| Sep 30, 2021 | -59,000.00 |
| Sep 30, 2021 | -59,000.00 |
| Jun 30, 2021 | -112,000.00 |
| Jun 30, 2021 | -112,000.00 |